Detailed diagnostic imaging

Article

Breaking news from the floor of ESCRS

Heidelberg Engineering has been showing off BluePeak laser autofluorescence, a diagnostic imaging modality that the company reports provides a functional map of the RPE-photoreceptor metabolism allowing users to non-invasively view the health of the RPE. The latest addition to this is the new RegionFinder software that the company claims allows users to quantify atrophic areas easily and to reliably monitor changes over time.

BluePeak is available for all SPECTRALIS SD-OCT models as is the new Anterior Segment Module, which is the company claims, bringing a new dimension to anterior segment imaging. The module consists of an add-on lens and software and allows the device to capture simultaneous IR and OCT imaging of the cornea, sclera and chamber angle to provide a detailed 3D view of the anterior chamber. According to the company the dual-angle white-to-white scan provides a perspective of the iris and lens that is not visible with single-angle scans.

Visitors to the booth were also invited to experience the Heidelberg Edge Perimeter. This perimeter technology offers two stimuli in one perimeter: the Flicker-Defined-Form and the Standard Automated Perimetry. According to the company, by combining this with the Heidelberg Retina Tomograph they have created the first visual field device to read in structural information and to conjointly display structural and functional data in the new Structure-Function Map.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.